BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25385595)

  • 1. Peptide and small molecule inhibitors of HECT-type ubiquitin ligases.
    Mund T; Lewis MJ; Maslen S; Pelham HR
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16736-41. PubMed ID: 25385595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor.
    Foote PK; Krist DT; Statsyuk AV
    Curr Protoc Chem Biol; 2017 Sep; 9(3):174-195. PubMed ID: 28910856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation.
    Jäckl M; Stollmaier C; Strohäker T; Hyz K; Maspero E; Polo S; Wiesner S
    J Mol Biol; 2018 Sep; 430(18 Pt B):3218-3233. PubMed ID: 29964046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
    Uchida C; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paving the way to targeting HECT ubiquitin ligases.
    Zinzalla G
    Future Med Chem; 2015; 7(16):2107-11. PubMed ID: 26510616
    [No Abstract]   [Full Text] [Related]  

  • 6. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain.
    Wiesner S; Ogunjimi AA; Wang HR; Rotin D; Sicheri F; Wrana JL; Forman-Kay JD
    Cell; 2007 Aug; 130(4):651-62. PubMed ID: 17719543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain.
    Ogunjimi AA; Briant DJ; Pece-Barbara N; Le Roy C; Di Guglielmo GM; Kavsak P; Rasmussen RK; Seet BT; Sicheri F; Wrana JL
    Mol Cell; 2005 Aug; 19(3):297-308. PubMed ID: 16061177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization of the HECT ubiquitin ligase NEDD4-2/NEDD4L is essential for polyubiquitin chain assembly.
    Todaro DR; Augustus-Wallace AC; Klein JM; Haas AL
    J Biol Chem; 2018 Nov; 293(47):18192-18206. PubMed ID: 30287686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting HECT-type E3 ligases - insights from catalysis, regulation and inhibitors.
    Fajner V; Maspero E; Polo S
    FEBS Lett; 2017 Sep; 591(17):2636-2647. PubMed ID: 28771691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2
    Zahid S; Gul M; Shafique S; Rashid S
    Comput Biol Med; 2022 Jul; 146():105660. PubMed ID: 35751189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HECT E3 ubiquitin ligase family genes involved in stem cell regulation and regeneration in planarians.
    Henderson JM; Nisperos SV; Weeks J; Ghulam M; Marín I; Zayas RM
    Dev Biol; 2015 Aug; 404(2):21-34. PubMed ID: 25956527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells.
    Quirit JG; Lavrenov SN; Poindexter K; Xu J; Kyauk C; Durkin KA; Aronchik I; Tomasiak T; Solomatin YA; Preobrazhenskaya MN; Firestone GL
    Biochem Pharmacol; 2017 Mar; 127():13-27. PubMed ID: 27979631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.
    Lechtenberg BC; Rajput A; Sanishvili R; Dobaczewska MK; Ware CF; Mace PD; Riedl SJ
    Nature; 2016 Jan; 529(7587):546-50. PubMed ID: 26789245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
    Sun A; Tian X; Chen Y; Yang W; Lin Q
    Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and Characterization of a DNA Aptamer Specifically Targeting Human HECT Ubiquitin Ligase WWP1.
    Tucker WO; Kinghorn AB; Fraser LA; Cheung YW; Tanner JA
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional validation of a highly specific Smurf2 inhibitor.
    Tessier TM; Chowdhury A; Stekel Z; Fux J; Sartori MA; Teyra J; Jarvik N; Chung J; Kurinov I; Sicheri F; Sidhu SS; Singer AU; Zhang W
    Protein Sci; 2024 Feb; 33(2):e4885. PubMed ID: 38147466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-lock inhibitory mechanism for fine-tuning enzyme activities of the HECT family E3 ligases.
    Wang Z; Liu Z; Chen X; Li J; Yao W; Huang S; Gu A; Lei QY; Mao Y; Wen W
    Nat Commun; 2019 Jul; 10(1):3162. PubMed ID: 31320636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural mechanisms of HECT-type ubiquitin ligases.
    Lorenz S
    Biol Chem; 2018 Jan; 399(2):127-145. PubMed ID: 29016349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-Based Probes for HECT E3 Ubiquitin Ligases.
    Byrne R; Mund T; Licchesi JDF
    Chembiochem; 2017 Jul; 18(14):1415-1427. PubMed ID: 28425671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.